evidence table
Myo-Inositol Sleep Quality Randomized Trial Evidence Table
Structured evidence table for Myo-Inositol Sleep Quality Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Myo-Inositol Sleep Quality Randomized Trial | The global prevalence of PCOS increased from 36.7 to 69.5 million between 1990 and 2021. | 3 | Subakathulla Sumayyah (2026) | Redox-endocrine triad in PCOS: can vitamin D, myo-inositol, and melatonin synergize as bioactive cocktails? |
| Myo-Inositol Sleep Quality Randomized Trial | Emerging evidence underscores that OS is not a mere byproduct of metabolic imbalance but a central driver that disrupts insulin signaling, amplifies androgen biosynthesis, and impairs folliculogenesis (,). | 3 | Subakathulla Sumayyah (2026) | Redox-endocrine triad in PCOS: can vitamin D, myo-inositol, and melatonin synergize as bioactive cocktails? |
| Myo-Inositol Sleep Quality Randomized Trial | Low-dose variants of OCPs have been observed with an increased risk of myocardial infarction and cardiovascular arterial disease (). | 3 | Subakathulla Sumayyah (2026) | Redox-endocrine triad in PCOS: can vitamin D, myo-inositol, and melatonin synergize as bioactive cocktails? |
| Myo-Inositol Sleep Quality Randomized Trial | 1 2 3 4 5 Polycystic ovary syndrome (PCOS) represents one of the most complex endocrine-metabolic disorders affecting women of reproductive age, characterized by a collection of reproductive, metabolic, and psychological manifestations (,). | 3 | Subakathulla Sumayyah (2026) | Redox-endocrine triad in PCOS: can vitamin D, myo-inositol, and melatonin synergize as bioactive cocktails? |
| Myo-Inositol Sleep Quality Randomized Trial | Conclusions and outlook Myo-inositol has a more acceptable safety profile than metformin, which is known to be associated with gastrointestinal adverse effects and, in rare cases, lactic acidosis. | 4 | Russo M (2025) | Metformin and Myo-Inositol: A Comparative Analysis. |
| Myo-Inositol Sleep Quality Randomized Trial | Background In the field of polycystic ovary syndrome (PCOS), metformin and myo-inositol are frequently employed to treat the endocrine-metabolic aspects of the condition. | 4 | Russo M (2025) | Metformin and Myo-Inositol: A Comparative Analysis. |
| Myo-Inositol Sleep Quality Randomized Trial | Accordingly, myo-inositol is sometimes considered as a nutraceutical alternative for metformin. | 4 | Russo M (2025) | Metformin and Myo-Inositol: A Comparative Analysis. |
Source documents